Eli Lilly Halts Work on Heart Drug After Poor Performance in Clinical Trial
Drug maker Eli Lilly & Co. announced on Monday that it had halted work on an experimental heart drug, after the drug, evacetrapib, failed to perform well in a clinical study. Lilly said Monday it was discontinuing development of evacetrapib, which was designed to ward off heart attacks and other cardiovascular problems by … [Read more...] about Eli Lilly Halts Work on Heart Drug After Poor Performance in Clinical Trial
Eli Lilly’s Experimental Lung Cancer Drug May Increase Risk of Blood Clots
In a report issued Tuesday, the U.S. Food and Drug Administration (FDA) raised concerns that Eli Lilly's experimental lung cancer drug necitumumab could increase the likelihood of blood clots. The agency found that the drug was associated with a greater chance of overall survival, but that it may also present a higher risk of … [Read more...] about Eli Lilly’s Experimental Lung Cancer Drug May Increase Risk of Blood Clots
